210 top medical experts on Medium chain acyl CoA dehydrogenase deficiency across 23 countries and 14 U.S. states, including 40 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Medium chain acyl CoA dehydrogenase deficiency: Medium chain acyl-CoA dehydrogenase (MCAD) deficiency (MCADD) is an inborn error of mitochondrial fatty acid oxidation characterized by a rapidly progressive metabolic crisis, often presenting as hypoketotic hypoglycemia, lethargy, vomiting, seizures and coma, which can be fatal in the absence of emergency medical intervention.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Support Organizations

Organizations Providing General Support

  • Synonyms: ACADM Deficiency,  deficiency of medium chain Acyl-CoA dehydrogenase,  Deficiency of Medium-Chain Acyl-Coa Dehydrogenase,  Carnitine Deficiency Secondary To Medium-Chain Acyl-Coa Dehydrogenase Deficiency,  MCAD Deficiency,  MCADH Deficiency,  Medium Chain Acyl-Coa Dehydrogenase Deficiency,  Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency,  Medium-chain Acyl-CoA dehydrogenase deficiency


    •   

            

                        


      Computing Expert Listing ...